MedCity News

Healthcare Bankruptcies Rise in Q1: 6 Things to Know

Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy

Angelini Pharma’s acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst’s top product is Firdapse, the first FDA-approved drug for a particular rare neuromuscular disorder.

By Frank Vinluan

MedCity Influencers

Transforming CTMS: An Operating Layer for Real-Time Trial Execution

CTMS platforms do not lack capability. They reflect an earlier architectural priority.

By Sidhant Khadanga

Policy

Debunked Episode 26: A Conversation on How to Improve Healthcare

Improving healthcare was a central theme of the latest episode of the Debunked Podcast. The discussion offered perspectives from Louisiana Republican Senator Bill Cassidy, HHS Secretary Robert Kennedy Jr., Devoted Health CEO Ed Park, and Dr. Ezekiel Emanuel, an oncologist and professor with University of Pennsylvania, and Debunked co-hosts Arundhati Parmar and Samir Batra.

By Stephanie Baum

Latest Video

Latest News

MedCity Influencers

Wooden mannequin holding a US $100 dollar bill on a defocused stethoscope background.

Patient Responsibility Is Rising — The Payment Experience Needs to Keep Up

Payment friction isn't always obvious. It shows up in extended accounts receivable timelines, increased billing inquiries, and patients who delay payment – not because they're unwilling to pay, but because the process made it harder than it needed to be.

By Stephanie O’Connor

MedCity Influencers

Lack of Trust, Not Technology, is What’s Stopping Health Plans from Meeting Their Mission and Financial Objectives

Healthcare often expects consumers to contort themselves around processes that were never built with them in mind — and that’s where the trust issue begins. With the looming arrival of HR1, how to fix it.

By Kendall Lockhart

Providers, Policy

conceptual image of people interacting with bar chart

How PE Is Adjusting Its Healthcare Playbook Now that It’s Under the Microscope

Lawmakers are applying increased scrutiny to private equity’s involvement in healthcare, particularly when it comes to physician practice roll-ups. But investor Matthew Bennett argues the pressure is reshaping rather than shrinking the sector, pushing firms away from roll-ups and toward strategies focused on improving outcomes and using technology to boost efficiency.

By Katie Adams

BioPharma, Pharma

Bayer Sees Opportunity With $300M Acquisition of Eye Drug Biotech

Perfuse Therapeutics brings Bayer an eye drug administered via an implant that controls the release of the therapy. This program is in mid-stage clinical development for glaucoma and diabetic retinopathy.

By Frank Vinluan

Health Tech

Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships

Rosarium Health's seed round was led by Kalos Ventures, with support from ResilienceVC, Rock Health Capital, Symphonic Capital, American Family Insurance Institute for Corporate and Social Impact, Black Tech Nations Ventures and The Council.

By Marissa Plescia

The Power Behind Enterprise EHR Software for Large Healthcare Systems

Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.

By Malvika Tarnekar, Director of Product Strategy, PrognoCIS by Bizmatics Inc

MedCity Influencers

Want to Show Your Nurses Appreciation? Fix Your Hospital Communications

For hospitals looking for ways to actually celebrate, support, and retain nurses, improving communication is one of the most immediate and controllable places to start.

By Melissa Hensley

MedCity Influencers

A Mandatory Shift: Why the CMS TEAM Model is an Important Opportunity for Health Systems

The most successful and high-performing health systems will approach TEAM not as a regulatory burden, but as a catalyst for transformation. They will use this moment to build the operating model, processes, workflows, and culture that position their health system for long-term success in value-based care.

By Jeff Gleason

The Hidden Administrative Tasks Draining Small Practices

Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

MedCity Influencers

Designing a National-Scale FHIR API Ecosystem Using Apigee: Architecture Patterns for Secure Healthcare Interoperability

Despite the widespread adoption of electronic health records (EHR) over the last couple of decades, essential patient information often gets trapped within the walls of individual hospital systems. Here's a potential solution.

By Sai Rupesh Kagga

Providers, Hospitals, Payers, Legal

Provider-Payer Tensions Brew in Courtrooms: 3 Recent Lawsuits

Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California Hospital Association sued Anthem over one of its out-of-network policies, Broward Health sued Florida Blue over alleged underpayment, and Jefferson Health sued Aetna over a Medicare Advantage hospital stay rule.

By Katie Adams

Health Tech, Payers

health insurance concept - umbrella covering wooden family of four

Parsley Health Wins Greater Insurance Coverage for its Functional Medicine

Parsley Health is now in-network with major insurers nationwide, including UnitedHealthcare, Aetna and Cigna.

By Marissa Plescia

BioPharma, Pharma

Madrigal Pharma Adds Another Genetic Medicine to Its Drug Combo Strategy in MASH

Madrigal Pharmaceuticals has licensed rights to an Arrowhead Pharmaceuticals small-interfering RNA therapy designed to address a particular genetic mutation associated with the fatty liver disease MASH. It’s Madrigal’s fourth business development deal of the past year and the company’s second one involving siRNA therapies.

By Frank Vinluan

MedCity Influencers

How I Learned To Trust AI as a Physical Therapist

If AI is going to be used in MSK care — or any area of healthcare — it needs clear, non-negotiable rules around it.

By Steven Griffin

MedCity Influencers

Kidney Care Is Value‑Based Care’s Toughest Economic Test — and It’s Working

For years, the central question was whether value-based care could work at all. Today, evidence from kidney care moves us beyond that debate. The more urgent questions are who can scale these models effectively and whether the system will sustain what’s working long enough for it to endure.

By Misha Palecek

MedCity Influencers

Healthcare Doesn’t Have an AI Problem — It Has a Readiness Problem

The path to scalable AI in healthcare will not be defined by a single breakthrough or technology. It will be shaped by the industry’s ability to address the foundational challenges that have existed for decades.

By Rachel Dunscombe

Hospitals, Providers

Is the Atrium-WakeMed Merger Already Hitting a Wall?

A proposed merger between Atrium Health and WakeMed Health is facing an early delay, with county commissioners having postponed a key vote over transparency concerns. State officials are warning the deal could hurt competition and drive up healthcare costs in the Raleigh area.

By Katie Adams